Regional lymphadenectomy for gallbladder cancer: rational extent, technical details, and patient outcomes

World J Gastroenterol. 2012 Jun 14;18(22):2775-83. doi: 10.3748/wjg.v18.i22.2775.

Abstract

Aim: To define the rational extent of regional lymphadenectomy for gallbladder cancer and to clarify its effect on long-term survival.

Methods: A total of 152 patients with gallbladder cancer who underwent a minimum of "extended" portal lymph node dissection (defined as en bloc removal of the first- and second-echelon nodes) from 1982 to 2010 were retrospectively analyzed. Based on previous studies, regional lymph nodes of the gallbladder were divided into first-echelon nodes (cystic duct or pericholedochal nodes), second-echelon nodes (node groups posterosuperior to the head of the pancreas or around the hepatic vessels), and more distant nodes.

Results: Among the 152 patients (total of 3352 lymph nodes retrieved, median of 19 per patient), 79 patients (52%) had 356 positive nodes. Among node-positive patients, the prevalence of nodal metastasis was highest in the pericholedochal (54%) and cystic duct (38%) nodes, followed by the second-echelon node groups (29% to 19%), while more distant node groups were only rarely (5% or less) involved. Disease-specific survival after R0 resection differed according to the nodal status (P < 0.001): most node-negative patients achieved long-term survival (median, not reached; 5-year survival, 80%), whereas among node-positive patients, 22 survived for more than 5 years (median, 37 mo; 5-year survival, 43%).

Conclusion: The rational extent of lymphadenectomy for gallbladder cancer should include the first- and second-echelon nodes. A considerable proportion of node-positive patients benefit from such aggressive lymphadenectomy.

Keywords: Gallbladder neoplasms; Lymph node excision; Lymphatic metastasis; Prognosis; Radical surgery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cholecystectomy
  • Digestive System Surgical Procedures* / adverse effects
  • Digestive System Surgical Procedures* / mortality
  • Disease-Free Survival
  • Female
  • Gallbladder Neoplasms / mortality
  • Gallbladder Neoplasms / pathology
  • Gallbladder Neoplasms / surgery*
  • Hepatectomy
  • Humans
  • Japan
  • Kaplan-Meier Estimate
  • Lymph Node Excision* / adverse effects
  • Lymph Node Excision* / mortality
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Pancreaticoduodenectomy
  • Retrospective Studies
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome